Serpin-glycosaminoglycan interactions

Methods in Enzymology

Volumn 501, Issue , 2011, Pages 105-137

  Rein, Chantelle M ^a   Desai, Umesh R ^b   Church, Frank C ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Antithrombin; Dermatan sulfate; Glycosaminoglycan; Heparin; Heparin cofactor II; Protein C inhibitor; Serpin

Indexed keywords

ALPHA 1 ANTITRYPSIN; ANTITHROMBIN; DERMATAN SULFATE; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HEPARIN; HEPARIN COFACTOR II; KALLISTATIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 3; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CLOTTING; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME INHIBITOR INTERACTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CARBOHYDRATE INTERACTION; PROTEIN CONFORMATION; PROTEIN STRUCTURE;

EID: 80955125299     PISSN: 00766879     EISSN: 15577988     Source Type: Book Series    
DOI: 10.1016/B978-0-12-385950-1.00007-9     Document Type: Chapter

References (108)

1. K. Aihara, H. Azuma, M. Akaike, Y. Ikeda, M. Sata, N. Takamori, S. Yagi, T. Iwase, Y. Sumitomo, H. Kawano, T. Yamada, and T. Fukuda Strain-dependent embryonic lethality and exaggerated vascular remodeling in heparin cofactor II deficient mice J. Clin. Invest. 117 2007 1514 1526 (Pubitemid 46871336)
2. R. Arcone, A. Chinali, N. Pozzi, M. Parafati, F. Maset, C. Pietropaolo, and V.D. Filippis Conformational and biochemical characterization of a biologically active rat recombinant Protease Nexin-1 expressed in E. coli Biochim. Biophys. Acta - Proteins & Proteomics 1794 2009 602 614
3. V. Arocas, S.C. Bock, S. Raja, S.T. Olson, and I. Björk Lysine 114 of antithrombin is of crucial importance for the affinity and kinetics of heparin pentasaccharide binding J. Biol. Chem. 276 2001 43809 43817
4. D.H. Atha, J.C. Lormeau, M. Petitou, R.D. Rosenberg, and J. Choay Contribution of 3-O- and 6-O-sulfated glucosamine residues in the heparin-induced conformational change in antithrombin III Biochemistry (NY) 26 1987 6454 6461
5. D.H. Atha, J.C. Lormeau, M. Petitou, R.D. Rosenberg, and J. Choay Contribution of monosaccharide residues in heparin binding to antithrombin III Biochemistry (NY) 24 1985 6723 6729 (Pubitemid 16207156)
6. T.P. Baglin, R.W. Carrell, F.C. Church, C.T. Esmon, and J.A. Huntington Crystal structures of native and thrombin-complexed heparin cofactor II reveal a multistep allosteric mechanism Proc. Natl. Acad. Sci. USA 99 2002 11079 11084 (Pubitemid 34920882)
7. L. Berry, A. Stafford, J. Fredenburgh, H. O'Brodovich, L. Mitchell, J. Weitz, M. Andrew, and A.K.C. Chan Investigation of the anticoagulant mechanisms of a covalent antithrombin-heparin complex J. Biol. Chem. 273 1998 34730 34736 (Pubitemid 29028163)
8. W. Bitomsky, and R.C. Wade Docking of glycosaminoglycans to heparin-binding proteins: Validation for aFGF, bFGF, and antithrombin and application to IL-8 J. Am. Chem. Soc. 121 1999 3004 3013 (Pubitemid 29189745)
9. L. Boucher, l.C. de, S. Bock, and P.L. Wintrode Conformational dynamics of antithrombin III with its allosteric activator heparin Biophys. J. 96 2009 69a
10. L.S. Busenlehner, and R.N. Armstrong Insights into enzyme structure and dynamics elucidated by amide H/D exchange mass spectrometry Arch. Biochem. Biophys. 433 2005 34
11. I. Capila, and R.J. Linhardt Heparin/protein interactions Angew. Chem. Int. Ed. 41 2002 390 412
12. R.W. Carrell, P.E. Stein, G. Fermi, and M.R. Wardell Biological implications of a 3 structure of dimeric antithrombin Structure 2 1994 257 270
13. W.J. Carter, E. Cama, and J.A. Huntington Crystal structure of thrombin bound to heparin J. Biol. Chem. 280 2005 2745 2749 (Pubitemid 40189381)
14. J. Clarkson, and I.D. Campbell Studies of protein-ligand interactions by NMR Biochem. Soc. Trans. 31 2003 1006 1009 (Pubitemid 37305036)
15. J. Corral, J. Rivera, C. Martinez, R. Gonzalez-Conejero, A. Minano, and V. Vicente Detection of conformational transformation of antithrombin in blood with crossed immunoelectrophoresis: New application for a classical method J. Lab. Clin. Med. 142 2003 298 305 (Pubitemid 37487399)
16. A. De Fatima, S.A. Fernandes, and A.A. Sabino Calixarenes as new platforms for drug design Curr. Drug Discov. Technol. 6 2009 151 170
17. A. Dementiev, M. Petitou, J. Herbert, and P.G.W. Gettins The ternary complex of antithrombin-anhydrothrombin-heparin reveals the basis of inhibitor specificity Nat. Struct. Mol. Biol. 11 2004 863
18. U.R. Desai, M. Petitou, I. Bjork, and S.T. Olson Mechanism of heparin activation of antithrombin: Evidence for an induced-fit model of allosteric activation involving two interaction subsites Biochemistry (NY) 37 1998 13033 13041 (Pubitemid 28433538)
19. U.R. Desai, M. Petitou, I. Björk, and S.T. Olson Mechanism of heparin activation of antithrombin J. Biol. Chem. 273 1998 7478 7487
20. U.R. Desai, S.C. Swanson, I. Björk Bock, and S.T. Olson Role of arginine 129 in heparin binding and activation of antithrombin J. Biol. Chem. 275 2000 18976 18984 (Pubitemid 30422863)
21. M. Dewerchin, J. Herault, G. Wallays, M. Petitou, P. Schaeffer, L. Millet, J.I. Weitz, L. Moons, D. Collen, P. Carmeliet, and J. Herbert Life-threatening thrombosis in mice with targeted Arg48-to-Cys mutation of the heparin-binding domain of antithrombin Circ. Res. 93 2003 1120 1126 (Pubitemid 37485044)
22. R. Einarsson The increase in human antithrombin III tryptophan fluorescence produced by heparin Biochim. Biophys. Acta - Protein, Structure 534 1978 165
23. R. Einarsson, and L. Andersson Binding of heparin to human antithrombin III as studied by measurements of tryptophan fluorescence Biochim. Biophys. Acta - Protein, Structure 490 1977 104 111 (Pubitemid 8015099)
24. S. Elg, and J. Deinum The interaction between captured human thrombin and antithrombin studied by surface plasmon resonance, and the effect of melagatran Spectroscopy 16 2002 257 270 (Pubitemid 36124842)
25. S. Faham, R.E. Hileman, J.R. Fromm, R.J. Linhardt, and D.C. Rees Heparin structure and interactions with basic fibroblast growth factor Science 271 1996 1116 1120 (Pubitemid 26075225)
26. A. Futamura, J.M. Beechem, and P.G.W. Gettins Conformational equilibrium of the reactive center loop of antithrombin examined by steady state and time-resolved fluorescence measurements: Consequences for the mechanism of factor Xa inhibition by antithrombin-heparin complexes Biochemistry (NY) 40 2001 6680 6687 (Pubitemid 32552792)
27. P.G.W. Gettins, P.A. Patston, and S.T. Olson Serpins: Structure 1996 Function and Biology. R. G. Landes Co. Austin
28. P.G.W. Gettins Serpin structure, mechanism, and function Chem. Rev. 102 2002 4751 4804
29. P.D.J. Grootenhuis, Boeckel Van, and A.A. Constant Constructing a molecular model of the interaction between antithrombin III and a potent heparin analog J. Am. Chem. Soc. 113 1991 2743 2747
30. M. Guerrini, S. Guglieri, B. Casu, G. Torri, P. Mourier, C. Boudier, and C. Viskov Antithrombin-binding octasaccharides and role of extensions of the active pentasaccharide sequence in the specificity and strength of interaction J. Biol. Chem. 283 2008 26662 26675
31. S. Hajmohammadi, K. Enjyoji, M. Princivalle, P. Christi, M. Lech, D. Beeler, H. Rayburn, J.J. Schwartz, S. Barzegar, A.I. de Agostini, M.J. Post, and R.D. Rosenberg Normal levels of anticoagulant heparan sulfate are not essential for normal hemostasis J. Clin. Invest. 111 2003 989
32. T. Hayashi, J. Nishioka, H. Kamada, K. Asanuma, H. Kondo, E.C. Gabazza, M. Ido, and K. Suzuki Characterization of a novel human protein C inhibitor (PCI) gene transgenic mouse useful for studying the role of PCI in physiological and pathological conditions J. Thromb. Haemost. 2 2004 949
33. L. He, T.K. Giri, C.P. Vicente, and D.M. Tollefsen Vascular dermatan sulfate regulates the antithrombotic activity of heparin cofactor II Blood 111 2008 4118 4125
34. L. He, C.P. Vicente, R.J. Westrick, D.T. Eitzman, and D.M. Tollefsen Heparin cofactor II inhibits arterial thrombosis after endothelial injury J. Clin. Invest. 109 2002 213
35. B.L. Henry, J. Connell, A. Liang, C. Krishnasamy, and U.R. Desai Interaction of antithrombin with sulfated, low molecular weight lignins J. Biol. Chem. 284 2009 20897 20908
36. W.J. Higgins, D.M. Fox, P.S. Kowalski, J.E. Nielsen, and D.M. Worrall Heparin enhances serpin inhibition of the cysteine protease cathepsin L J. Biol. Chem. 285 2010 3722 3729
37. J.A. Huntington, M. Kjellberg, and J. Stenflo Crystal structure of protein c inhibitor provides insights into hormone binding and heparin activation Structure 11 2003 205
38. J.A. Huntington, S.T. Olson, B. Fan, and P.G.W. Gettins Mechanism of heparin activation of antithrombin. Evidence for reactive center loop preinsertion with expulsion upon heparin binding Biochemistry (NY) 35 1996 8495 8503 (Pubitemid 26240183)
39. K. Ishiguro, T. Kojima, K. Kadomatsu, Y. Nakayama, A. Takagi, M. Suziki, N. Takeda, M. Ito, K. Yamamoto, T. Matsushita, K. Kusugami, and T. Muramatsu Complete antithrombin deficiency in mice results in embryonic lethality J. Clin. Invest. 106 2000 873
40. M.A. Jairajpuri, A. Lu, U. Desai, S.T. Olson, I. Bjork, and S.C. Bock Antithrombin III phenylalanines 122 and 121 contribute to its high affinity for heparin and its conformational activation J. Biol. Chem. 278 2003 15941 15950 (Pubitemid 36799712)
41. L. Jin, J.P. Abrahams, R. Skinner, M. Petitou, R.N. Pike, and R.W. Carrell The anticoagulant activation of antithrombin by heparin Proc. Natl. Acad. Sci. USA 94 1997 14683 14688 (Pubitemid 28041434)
42. D.J.D. Johnson, and J.A. Huntington Crystal structure of antithrombin in a heparin-bound intermediate state Biochemistry (NY) 42 2003 8712 8719 (Pubitemid 36899814)
43. D.J.D. Johnson, J. Langdown, and J.A. Huntington Molecular basis of factor IXa recognition by heparin-activated antithrombin revealed by a 1.7- structure of the ternary complex Proc. Natl. Acad. Sci. USA 107 2010 645 650
44. D.J.D. Johnson, J. Langdown, W. Li, S.A. Luis, T.P. Baglin, and J.A. Huntington Crystal structure of monomeric native antithrombin reveals a novel reactive center loop conformation J. Biol. Chem. 281 2006 35478 35486 (Pubitemid 46036584)
45. Y. Kanagawa, T. Shigekiyo, K. Aihara, M. Akaike, H. Azuma, and T. Matsumoto Molecular mechanism of Type I congenital heparin cofactor (HC) II deficiency caused by a missense mutation at reactive P2 site: HC II Tokushima Thromb. Haemost. 85 2001 101
46. S.H. Kim, and K.L. Kiick Heparin-mimetic sulfated peptides with modulated affinities for heparin-binding peptides and growth factors Peptides 28 2007 2125 2136 (Pubitemid 47603258)
47. M. Kjellberg, T. Ikonomou, and J. Stenflo The cleaved and latent forms of antithrombin are normal constituents of blood plasma: A quantitative method to measure cleaved antithrombin J. Thromb. Haemost. 4 2006 168 176
48. D.A. Lane, R.J. Olds, M. Boisclair, V. Chowdhury, S.L. Thein, D.N. Cooper, M. Blajchman, D. Perry, J. Emmerich, and M. Aiach Antithrombin III mutation database: First update. For the Thrombin and its Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis Thromb. Haemost. 70 1993 361
49. D.A. Lane, G. Kunz, R.J. Olds, and S.L. Thein Molecular genetics of antithrombin deficiency Blood Rev. 10 1996 59
50. J. Langdown, K.J. Belzar, W.J. Savory, T.P. Baglin, and J.A. Huntington The critical role of hinge-region expulsion in the induced-fit heparin binding mechanism of antithrombin J. Mol. Biol. 386 2009 1278
51. J. Langdown, D.J.D. Johnson, T.P. Baglin, and J.A. Huntington Allosteric activation of antithrombin critically depends upon hinge region extension J. Biol. Chem. 279 2004 47288 47297 (Pubitemid 39518386)
52. M.K. Lee, and A.D. Lander Analysis of affinity and structural selectivity in the binding of proteins to glycosaminoglycans: Development of a sensitive electrophoretic approach Proc. Natl. Acad. Sci. USA 88 1991 2768 2772 (Pubitemid 21916500)
53. W. Li, T.E. Adams, M. Kjellberg, J. Stenflo, and J.A. Huntington Structure of native protein c inhibitor provides insight into its multiple functions J. Biol. Chem. 282 2007 13759 13768 (Pubitemid 47100522)
54. W. Li, T.E. Adams, J. Nangalia, C.T. Esmon, and J.A. Huntington Molecular basis of thrombin recognition by protein C inhibitor revealed by the 1.6- structure of the heparin-bridged complex Proc. Natl. Acad. Sci. USA 105 2008 4661 4666 (Pubitemid 351753803)
55. W. Li, D.J.D. Johnson, C.T. Esmon, and J.A. Huntington Structure of the antithrombin-thrombin-heparin ternary complex reveals the antithrombotic mechanism of heparin Nat. Struct. Mol. Biol. 11 2004 857
56. P.C.Y. Liaw, R.C. Austin, J.C. Fredenburgh, A.R. Stafford, and J.I. Weitz Comparison of heparin- and dermatan sulfate-mediated catalysis of thrombin inactivation by heparin cofactor II J. Biol. Chem. 274 1999 27597 27604
57. P. Lin, U. Sinha, and A. Betz Antithrombin binding of low molecular weight heparins and inhibition of factor Xa Biochim. Biophys. Acta - General Subjects 1526 2001 105
58. L. Liu, N. Mushero, L. Hedstrom, and A. Gershenson Short-lived protease-serpin complexes: Partial disruption of the rat trypsin active site Protein Sci. 16 2007 2403 2411 (Pubitemid 350036747)
59. M. Maccarana, S. Kalamajski, M. Kongsgaard, S.P. Magnusson, A. Oldberg, and A. Malmstrom Dermatan sulfate epimerase 1-deficient mice have reduced content and changed distribution of iduronic acids in dermatan sulfate and an altered collagen structure in skin Mol. Cell. Biol. 29 2009 5517 5528
60. J.B. Madsen, D.M. Dupont, T.B. Andersen, A.F. Nielsen, L. Sang, D.M. Brix, J.K. Jensen, T. Broos, M.L.V. Hendrickx, A. Christensen, J. Kjems, and P.A. Andreasen RNA aptamers as conformational probes and regulatory agents for plasminogen activator inhibitor-1 Biochemistry 49 2010 4103 4115
61. M.M. Maimone, and D.M. Tollefsen Structure of a dermatan sulfate hexasaccharide that binds to heparin cofactor II with high affinity J. Biol. Chem. 265 1990 18263 18271
62. H. Majdoub, M.B. Mansour, F. Chaubet, M.S. Roudesli, and R.M. Maaroufi Anticoagulant activity of a sulfated polysaccharide from the green alga Arthrospira platensis Biochim. Biophys. Acta - General Subjects 1790 2009 1377
63. M.B. Mansour, M. Dhahri, M. Hassine, N. Ajzenberg, L. Venisse, V. Ollivier, F. Chaubet, M. Jandrot-Perrus, and R.M. Maaroufi Highly sulfated dermatan sulfate from the skin of the ray Raja montagui: Anticoagulant activity and mechanism of action Comp. Biochem. Physiol. B Biochem. Mol. Biol. 156 2010 206
64. I. Martinez-Martinez, A. Ordonez, J.A. Guerrero, S. Pedersen, A. Minano, R. Teruel, L. Velazquez, S.R. Kristensen, V. Vicente, and J. Corral Effects of acrolein, a natural occurring aldehyde, on the anticoagulant serpin antithrombin FEBS Lett. 583 2009 3165
65. I. Martinez-Martinez, A. Ordonez, J. Navarro-Fernandez, A. Perez-Lara, R. Gutierrez-Gallego, R. Giraldo, C. Martinez, E. Llop, V. Vicente, and J. Corral Antithrombin Murcia (K241E) causing antithrombin deficiency: A possible role for altered glycosylation Haematologica 95 2010 1358 1365
66. J.L. Meagher, J.M. Beechem, S.T. Olson, and P.G.W. Gettins Deconvolution of the fluorescence emission spectrum of human antithrombin and identification of the tryptophan residues that are responsive to heparin binding J. Biol. Chem. 273 1998 23283 23289 (Pubitemid 28417514)
67. J.L. Meagher, S.T. Olson, and P.G.W. Gettins Critical role of the linker region between helix D and strand 2A in heparin activation of antithrombin J. Biol. Chem. 275 2000 2698 2704 (Pubitemid 30082039)
68. B.H. Monien, C. Krishnasamy, S.T. Olson, and U.R. Desai Importance of tryptophan 49 of antithrombin in heparin binding and conformational activation Biochemistry (NY) 44 2005 11660 11668 (Pubitemid 41262699)
69. B. Nordenman,. Danielsson, and I. Björk The binding of low-affinity and high-affinity heparin to antithrombin Eur. J. Biochem. 90 1978 1 6 (Pubitemid 9013119)
70. D. O'Keeffe, S.T. Olson, N. Gasiunas, J. Gallagher, T.P. Baglin, and J.A. Huntington The heparin binding properties of heparin cofactor II suggest an antithrombin-like activation mechanism J. Biol. Chem. 279 2004 50267 50273 (Pubitemid 39577841)
71. S.T. Olson, I. Björk, R. Sheffer, P.A. Craig, J.D. Shore, and J. Choay Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement J. Biol. Chem. 267 1992 12528 12538
72. S.T. Olson, K.R. Srinivasan, I. Björk, and J.D. Shore Binding of high affinity heparin to antithrombin III. Stopped flow kinetic studies of the binding interaction J. Biol. Chem. 256 1981 11073 11079 (Pubitemid 12181591)
73. S.T. Olson, P.E. Bock, and R. Sheffer Quantitative evaluation of solution equilibrium binding interactions by affinity partitioning: Application to specific and nonspecific protein-heparin interactions Arch. Biochem. Biophys. 286 1991 533
74. S.T. Olson, A.M. Frances-Chmura, R. Swanson, I. Björk, and G. Zettlmeissl Effect of individual carbohydrate chains of recombinant antithrombin on heparin affinity and on the generation of glycoforms differing in heparin affinity Arch. Biochem. Biophys. 341 1997 212
75. M.S.G. Pavão, P.A.S. Mourão, B. Mulloy, and D.M. Tollefsen A unique dermatan sulfate-like glycosaminoglycan from ascidian J. Biol. Chem. 270 1995 31027 31036
76. M. Pearce, S. Bottomley, R. Pike, and A. Lesk Serpin conformations D. Lomas, G. Silverman, Molecular and cellular aspects of the serpinopathies and disorders in serpin activity 2006 World Scientific Singapore
77. L. Pellegrini, D.F. Burke, F. von Delft, B. Mulloy, and T.L. Blundell Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin Nature 407 2000 1029 1034
78. J.E. Phillips, S.T. Cooper, E.E. Potter, and F.C. Church Mutagenesis of recombinant protein C inhibitor reactive site residues alters target proteinase specificity J. Biol. Chem. 269 1994 16696 16700 (Pubitemid 24200428)
79. M.W. Piepkorn Dansyl (5-dimethylaminonaphthalene-1-sulphonyl)-heparin binds antithrombin III and platelet factor 4 at separate sites Biochem. J. 196 1981 649 651 (Pubitemid 11090141)
80. M.W. Piepkorn, D. Lagunoff, and G. Schmer Binding of heparin to antithrombin III: The use of dansyl and rhodamine labels Arch. Biochem. Biophys. 205 1980 315
81. A. Raghuraman, P.D. Mosier, and U.R. Desai Understanding dermatan sulfate heparin cofactor II interaction through virtual library screening ACS Med. Chem Lett. 1 2010 281 285
82. A. Raghuraman, P.D. Mosier, and U.R. Desai Finding a needle in a haystack: Development of a combinatorial virtual screening approach for identifying high specificity heparin/heparan sulfate sequence(s) J. Med. Chem. 49 2006 3553 3562 (Pubitemid 43902461)
83. B. Richard, R. Swanson, and S.T. Olson The signature 3-O-sulfo group of the anticoagulant heparin sequence is critical for heparin binding to antithrombin but is not required for allosteric activation J. Biol. Chem. 284 2009 27054 27064
84. G. Rovelli, S.R. Stone, A. Guidolin, J. Sommer, and D. Monard Characterization of the heparin-binding site of glia-derived nexin/protease nexin-1 Biochemistry (NY) 31 1992 3542 3549
85. T.R. Rudd, E.A. Yates, and M. Hricovini Spectroscopic and theoretical approaches for the determination of heparin saccharide structure and the study of protein-glycosaminoglycan complexes in solution Curr. Med. Chem. 16 2009 4750 4766
86. T.R. Rudd, S.E. Guimond, M.A. Skidmore, L. Duchesne, M. Guerrini, G. Torri, C. Cosentino, A. Brown, D.T. Clarke, J.E. Turnbull, D.G. Fernig, and E.A. Yates Influence of substitution pattern and cation binding on conformation and activity in heparin derivatives Glycobiology 17 2007 983 993 (Pubitemid 47423888)
87. T.R. Rudd, R.J. Nichols, and E.A. Yates Selective detection of protein secondary structural changes in solution protein polysaccharide complexes using vibrational circular dichroism (VCD) J. Am. Chem. Soc. 130 2008 2138 2139 (Pubitemid 351287973)
88. J.D. San Antonio, and A.D. Lander Affinity coelectrophoresis of proteoglycan-protein complexes Methods Mol. Biol. 171 2001 401 414
89. S. Schedin-Weiss, V. Arocas, S.C. Bock, S.T. Olson, and I. Björk Specificity of the basic side chains of Lys114, Lys125, and Arg129 of antithrombin in heparin binding Biochemistry (NY) 41 2002 12369 12376
90. S. Schedin-Weiss, U.R. Desai, S.C. Bock, P.G.W. Gettins, S.T. Olson, and I. Björk Importance of lysine 125 for heparin binding and activation of antithrombin Biochemistry (NY) 41 2002 4779 4788 (Pubitemid 34298644)
91. S. Schedin-Weiss, U.R. Desai, S.C. Bock, S.T. Olson, and I. Björk Roles of N-terminal region residues Lys11, Arg13, and Arg24 of antithrombin in heparin recognition and in promotion and stabilization of the heparin-induced conformational change Biochemistry 43 2004 675 683 (Pubitemid 38114054)
92. S. Schedin-Weiss, B. Richard, R. Hjelm, and S.T. Olson Antiangiogenic forms of antithrombin specifically bind to the anticoagulant heparin sequence Biochemistry (NY) 47 2008 13610 13619
93. J. Schlessinger, A.N. Plotnikov, O.A. Ibrahimi, A.V. Eliseenkova, B.K. Yeh, A. Yayon, R.J. Linhardt, and M. Mohammadi Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization Mol. Cell 6 2000 743 750
94. A.J. Schulze, P.W. Frohnert, R.A. Engh, and R. Huber Evidence for the extent of insertion of the active site loop of intact.alpha.1 proteinase inhibitor in.beta.-sheet A Biochemistry (NY) 31 1992 7560 7565
95. R.A. Shirk, N. Parthasarathy, J.D. San Antonio, F.C. Church, and W.D. Wagner Altered dermatan sulfate structure and reduced heparin cofactor II-stimulating activity of biglycan and decorin from human atherosclerotic plaque J. Biol. Chem. 275 2000 18085 18092 (Pubitemid 30414757)
96. K. Strandberg, P. Bhiladvala, J. Holm, and J. Stenflo A new method to measure plasma levels of activated protein C in complex with protein C inhibitor in patients with acute coronary syndromes Blood Coag. Fibrinol. 12 2001 503 510 (Pubitemid 33022513)
97. V.J. Streusand, I. Björk, P.G.W. Gettins, M. Petitou, and S.T. Olson Mechanism of acceleration of antithrombin-proteinase reactions by low affinity heparin J. Biol. Chem. 270 1995 9043 9051
98. K. Takamoto, and M.R. Chance Radiolytic protein footprinting with mass spectrometry to probe the structure of macromolecular complexes Annu. Rev. Biophys. Biomol. Struct. 35 2006 251 276 (Pubitemid 43877378)
99. T. Toida, R.E. Hileman, A.E. Smith, P.I. Vlahova, and R.J. Linhardt Enzymatic preparation of heparin oligosaccharides containing antithrombin III binding sites J. Biol. Chem. 271 1996 32040 32047 (Pubitemid 26422232)
100. Y. Tsutsui, L. Liu, A. Gershenson, and P.L. Wintrode The conformational dynamics of a metastable serpin studied by hydrogen exchange and mass spectrometry Biochemistry (NY) 45 2006 6561 6569 (Pubitemid 43825356)
101. P. Uhrin, M. Dewerchin, M. Hilpert, P. Chrenek, C. Schöfer, M. Zechmeister-Machhart, G. Krönke, A. Vales, P. Carmeliet, B.R. Binder, and M. Geiger Disruption of the protein C inhibitor gene results in impaired spermatogenesis and male infertility J. Clin. Invest. 106 2000 1531
102. P. Uhrin, C. Schöfer, J. Zaujec, R. Lubos, M. Hilpert, K. Weipoltshammer, I. Jerabeck, I. Pertzkall, M. Furtmüller, M. Dewerchin, B.R. Binder, and M. Geiger Male fertility and protein C inhibitor/plasminogen activator inhibitor-3 (PCI): Localization of PCI in mouse testis and failure of single plasminogen activator knockout to restore spermatogenesis in PCI-deficient mice Fertil. Steril. 88 2007 1049
103. H. Verli, and J.A. Guimaraes Insights into the induced-fit mechanism in antithrombin - Heparin interaction using molecular dynamics simulations J. Mol. Graph. Modell. 24 2005 203
104. C.P. Vicente, L. He, M.S.G. Pavao, and D.M. Tollefsen Antithrombotic activity of dermatan sulfate in heparin cofactor II-deficient mice Blood 104 2004 3965 3970 (Pubitemid 39620145)
105. G.T.M. Wagenaar, A.J.H. van Vuuren, M. Girma, M.J. Tiekstra, L. Kwast, J.G. Koster, A.W. Rijneveld, M.G.L.M. Elisen, T. van der Poll, and J.C.M. Meijers Characterization of transgenic mice that secrete functional human protein C inhibitor into the circulation Thromb. Haemost. 83 2000 93
106. M. Yanada, T. Kojima, K. Ishiguro, Y. Nakayama, K. Yamamoto, T. Matsushita, K. Kadomatsu, M. Nishimura, T. Muramatsu, and H. Saito Impact of antithrombin deficiency in thrombogenesis: Lipopolysaccharide and stress-induced thrombus formation in heterozygous antithrombin-deficient mice Blood 99 2002 2455 2458 (Pubitemid 34525432)
107. F. Zhang, Y. Wu, Q. Ma, D. Hoppensteadt, J. Fareed, and R.J. Linhardt Studies on the effect of calcium in interactions between heparin and heparin cofactor II using surface plasmon resonance Clin. Appl. Thromb. Hemost. 10 2004 249 257 (Pubitemid 38982049)
108. X. Zheng, P.L. Wintrode, and M.R. Chance Complementary structural mass spectrometry techniques reveal local dynamics in functionally important regions of a metastable serpin Structure 16 2008 38 51